Coquí Radiopharmaceuticals Corp.

Coquí Radiopharmaceuticals Corp. mission is to create a commercially scalable and reliable supply of medical radioisotopes in the US, specifically Molybdenum 99 (Mo-99), in a state-of-the-art production facility using proven technology.

Coquí’s Facility Site is in the U.S. Premier Region for Nuclear – Oak Ridge, Tennessee.

“Coquí is not reinventing the wheel. We are streamlining the production process, so the U.S. has a readily available supply of medical radioisotopes, with greater access and lower costs for patients.”

— Carmen I. Bigles, President and CEO of Coquí Pharma